BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 36047963)

  • 1. Cancerous pH-responsive polycarboxybetaine-coated lipid nanoparticle for smart delivery of siRNA against subcutaneous tumor model in mice.
    Sung YJ; Guo H; Ghasemizadeh A; Shen X; Chintrakulchai W; Kobayashi M; Toyoda M; Ogi K; Michinishi J; Ohtake T; Matsui M; Honda Y; Nomoto T; Takemoto H; Miura Y; Nishiyama N
    Cancer Sci; 2022 Dec; 113(12):4339-4349. PubMed ID: 36047963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fine tuning of the net charge alternation of polyzwitterion surfaced lipid nanoparticles to enhance cellular uptake and membrane fusion potential.
    Homma K; Miura Y; Kobayashi M; Chintrakulchai W; Toyoda M; Ogi K; Michinishi J; Ohtake T; Honda Y; Nomoto T; Takemoto H; Nishiyama N
    Sci Technol Adv Mater; 2024; 25(1):2338785. PubMed ID: 38646148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of amino acid-modified biodegradable lipid nanoparticles for siRNA delivery.
    Patel P; Fetse J; Lin CY; Guo Y; Hasan MR; Nakhjiri M; Zhao Z; Jain A; Cheng K
    Acta Biomater; 2022 Dec; 154():374-384. PubMed ID: 36191773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hydrophobic scaffolds of pH-sensitive cationic lipids contribute to miscibility with phospholipids and improve the efficiency of delivering short interfering RNA by small-sized lipid nanoparticles.
    Sato Y; Okabe N; Note Y; Hashiba K; Maeki M; Tokeshi M; Harashima H
    Acta Biomater; 2020 Jan; 102():341-350. PubMed ID: 31733331
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding structure-activity relationships of pH-sensitive cationic lipids facilitates the rational identification of promising lipid nanoparticles for delivering siRNAs in vivo.
    Sato Y; Hashiba K; Sasaki K; Maeki M; Tokeshi M; Harashima H
    J Control Release; 2019 Feb; 295():140-152. PubMed ID: 30610950
    [TBL] [Abstract][Full Text] [Related]  

  • 6. pH-labile PEGylation of siRNA-loaded lipid nanoparticle improves active targeting and gene silencing activity in hepatocytes.
    Hashiba K; Sato Y; Harashima H
    J Control Release; 2017 Sep; 262():239-246. PubMed ID: 28774839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Charge-reversible lipid derivative: A novel type of pH-responsive lipid for nanoparticle-mediated siRNA delivery.
    Hirai Y; Saeki R; Song F; Koide H; Fukata N; Tomita K; Maeda N; Oku N; Asai T
    Int J Pharm; 2020 Jul; 585():119479. PubMed ID: 32473372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acidic pH-induced changes in lipid nanoparticle membrane packing.
    Koitabashi K; Nagumo H; Nakao M; Machida T; Yoshida K; Sakai-Kato K
    Biochim Biophys Acta Biomembr; 2021 Aug; 1863(8):183627. PubMed ID: 33901441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction Kinetics of Individual mRNA-Containing Lipid Nanoparticles with an Endosomal Membrane Mimic: Dependence on pH, Protein Corona Formation, and Lipoprotein Depletion.
    Aliakbarinodehi N; Gallud A; Mapar M; Wesén E; Heydari S; Jing Y; Emilsson G; Liu K; Sabirsh A; Zhdanov VP; Lindfors L; Esbjörner EK; Höök F
    ACS Nano; 2022 Dec; 16(12):20163-20173. PubMed ID: 36511601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemistry of Lipid Nanoparticles for RNA Delivery.
    Eygeris Y; Gupta M; Kim J; Sahay G
    Acc Chem Res; 2022 Jan; 55(1):2-12. PubMed ID: 34850635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitation of physiological and biochemical barriers to siRNA liver delivery via lipid nanoparticle platform.
    Xu Y; Ou M; Keough E; Roberts J; Koeplinger K; Lyman M; Fauty S; Carlini E; Stern M; Zhang R; Yeh S; Mahan E; Wang Y; Slaughter D; Gindy M; Raab C; Thompson C; Hochman J
    Mol Pharm; 2014 May; 11(5):1424-34. PubMed ID: 24588618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of helper lipids in lipid nanoparticles (LNPs) designed for oligonucleotide delivery.
    Cheng X; Lee RJ
    Adv Drug Deliv Rev; 2016 Apr; 99(Pt A):129-137. PubMed ID: 26900977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing the siRNA knockdown efficiency of lipid nanoparticles by morphological transformation with the use of dihydrosphingomyelin as a helper lipid.
    Hashimoto M; Yonezawa S; Furan S; Nitta C; Maeda N; Tomita K; Yokouchi A; Koide H; Asai T
    Biomater Sci; 2023 May; 11(9):3269-3277. PubMed ID: 36939181
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Light-Activated siRNA Endosomal Release (LASER) by Porphyrin Lipid Nanoparticles.
    Mo Y; Cheng MHY; D'Elia A; Doran K; Ding L; Chen J; Cullis PR; Zheng G
    ACS Nano; 2023 Mar; 17(5):4688-4703. PubMed ID: 36853331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neutralization of negative charges of siRNA results in improved safety and efficient gene silencing activity of lipid nanoparticles loaded with high levels of siRNA.
    Sato Y; Matsui H; Sato R; Harashima H
    J Control Release; 2018 Aug; 284():179-187. PubMed ID: 29936118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stabilization of Ostwald ripening in low molecular weight amino lipid nanoparticles for systemic delivery of siRNA therapeutics.
    Gindy ME; Feuston B; Glass A; Arrington L; Haas RM; Schariter J; Stirdivant SM
    Mol Pharm; 2014 Nov; 11(11):4143-53. PubMed ID: 25317715
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced endosomal/lysosomal escape by distearoyl phosphoethanolamine-polycarboxybetaine lipid for systemic delivery of siRNA.
    Li Y; Cheng Q; Jiang Q; Huang Y; Liu H; Zhao Y; Cao W; Ma G; Dai F; Liang X; Liang Z; Zhang X
    J Control Release; 2014 Feb; 176():104-14. PubMed ID: 24365128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Determination of the interior pH of lipid nanoparticles using a pH-sensitive fluorescent dye-based DNA probe.
    Zhao B; Kamanzi A; Zhang Y; Chan KYT; Robertson M; Leslie S; Cullis PR
    Biosens Bioelectron; 2024 May; 251():116065. PubMed ID: 38330772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient Delivery of Globotriaosylceramide Synthase siRNA using Polyhistidine-Incorporated Lipid Nanoparticles.
    Kim IG; Jung WH; You G; Lee H; Shin YJ; Lim SW; Chung BH; Mok H
    Macromol Biosci; 2023 Apr; 23(4):e2200423. PubMed ID: 36728673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Development of siRNA Delivery Targeting the Tumor Microenvironment with a New Functional Device].
    Sakurai Y
    Yakugaku Zasshi; 2019; 139(11):1357-1363. PubMed ID: 31685731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.